Abstract
This chapter will focus on hypofractionated, stereotactic body radiation treatment (SBRT) of localized prostate cancer using a homogeneous dose distribution. The biologic rationale for hypofractionation in the management of prostate cancer has been addressed in a previous chapter. Patient selection, treatment planning, dose specification, treatment delivery, outcome measures, and published experience using the CyberKnife® Radiosurgery System for prostate cancer will be reviewed.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Brenner DJ (2003) Hypofractionation for prostate cancer radiotherapy – what are the issues? Int J Radiat Oncol Biol Phys 57:912–914
Collins CD, Lloyd-Davies RW, Swan AV (1991) Radical external beam radiotherapy for localised carcinoma of the prostate using a hypofractionation technique. Clin Oncol (R Coll Radiol) 3:127–132
Lloyd-Davies RW, Collins CD, Swan AV (1990) Carcinoma of prostate treated by radical external beam radiotherapy using hypofractionation. Twenty-two years’ experience (1962–1984). Urology 36:107–111
Madsen BL, Hsi RA, Pham HT et al (2007) Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: first clinical trial results. Int J Radiat Oncol Biol Phys 67:1099–1105
Pham HT, Song G, Badiozamani K et al (2010) Five-year outcome of stereotactic hypofractionated accurate radiotherapy of the prostate (sharp) for patients with low-risk prostate cancer. In: ASTRO Annual Meeting, vol. 78, S58pp
Buyyounouski MK, Balter P, Lewis B et al (2010) Stereotactic body radiotherapy for early-stage non-small-cell lung cancer: report of the ASTRO Emerging Technology Committee. Int J Radiat Oncol Biol Phys 78:3–10
Xie Y, Djajaputra D, King CR et al (2008) Intrafractional motion of the prostate during hypofractionated radiotherapy. Int J Radiat Oncol Biol Phys 72:236–246
King CR, Brooks JD, Gill H et al (2009) Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial. Int J Radiat Oncol Biol Phys 73:1043–1048
Friedland JL, Freeman DE, Masterson-McGary ME et al (2009) Stereotactic body radiotherapy: an emerging treatment approach for localized prostate cancer. Technol Cancer Res Treat 8:387–392
Katz AJ, Santoro M, Ashley R et al (2010) Stereotactic body radiotherapy for organ-confined prostate cancer. BMC Urol 10:1
King CR, Brooks JD, Gill H et al (2011) Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer. Int J Radiat Oncol Biol Phys
Meier R, Sanda M, Kaplan I (2010) Robotic radiosurgery for organ-confined prostate cancer: early toxicity outcomes from a multi-institutional trial. J Urol 183:E785
Freeman DE, King CR (2011) Stereotactic body radiotherapy for low-risk prostate cancer: five-year outcomes. Radiat Oncol 6:3
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Freeman, D., Masterson-McGary, M.E. (2012). Prostate Radiosurgery with Homogeneous Dose Distribution: A Summary of Outcomes So Far. In: Ponsky, L., Fuller, D., Meier, R., Ma, C. (eds) Robotic Radiosurgery. Treating Prostate Cancer and Related Genitourinary Applications. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-11495-3_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-11495-3_13
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-11494-6
Online ISBN: 978-3-642-11495-3
eBook Packages: MedicineMedicine (R0)